New Delhi: India's drug regulator has cancelled the rapid diagnostic kit import licences of three firms and suspended that of 15 others saying the USFDA has removed the manufacturers from their list of coronavirus serology test kits with directions that they should not be distributed.The three firms are Cadila Healthcare, MDAAC International and N W Overseas while the 15 companies include Transasia Bio-Medicals, Cosmic Scientific, Inbios India, S D Biosensor, Accurex Biomedicals, Biohouse Solutions and Trivitron Healthcare among others.
The companies were issued a show cause notices on July 17 asking why their import licenscs shall not be cancelled since the diagnostic kits of the manufacturers have been removed by USFDA with direction.